A med spa investigation can start over something you thought was routine. By the time you realize the government is looking, a nurse, a former employee, or a billing pattern has already pointed agents in your direction.
A med spa investigation can start over something you thought was routine. A Botox injection, a weight-loss prescription, a referral arrangement, a product you ordered from overseas to save money. By the time you realize the government is looking, a nurse, a medical director who was never really involved, a former employee, or a billing pattern has already pointed agents in your direction.
Med spas live in a gray zone, and prosecutors know it. The industry sits where medicine, cosmetics, controlled substances, and aggressive marketing meet, and the rules about who can do what, under whose supervision, with which drugs, change from state to state and are easy to get wrong.
That gray zone is exactly why these cases are being pursued. Regulators see fast-growing clinics run by non-physicians, prescribing controlled or imported drugs, sometimes billing insurance, sometimes paying for referrals. Federal and state agencies have made this industry a priority, and the weight-loss drug boom has only sharpened the focus.
What is at risk is not just a fine. It is your professional license, your business, and in serious cases your freedom. An unlicensed-practice or controlled-substance charge can end a nursing or medical career. A healthcare fraud or kickback case can become a federal felony. The clinic you built can be shut down, its accounts frozen, its assets forfeited.
The reason to take this seriously now is that med spa cases rarely stay small. What starts as a board complaint or one patient's bad outcome can grow into a criminal investigation involving the DEA, the FDA, or the Department of Justice. The earlier you understand what you are facing, the more you can do about it.
These investigations almost never start with an arrest. They start with a thread someone pulls.
A patient has a bad reaction to a filler or an infusion and complains to the state health department. A former nurse or front-desk employee reports that the supervising physician never actually saw patients. A pharmacy or distributor flags unusual orders of Botox, fillers, or semaglutide. A competitor files a complaint. An insurer's audit catches billing that does not match what was actually done.
The weight-loss drug surge created a whole new category of risk. Clinics ordering compounded or imported GLP-1 drugs, prescribing them through quick telehealth visits, or selling them without a real evaluation have drawn attention from the FDA, the DEA, and state boards. Products sourced from outside the United States raise the possibility of misbranded or adulterated drug charges.
From a complaint or a data flag, the case grows. Investigators request records. They send undercover patients. They interview staff. They pull prescribing data and bank records. State boards and criminal investigators often work side by side, and information from a routine board inquiry can feed a criminal file.
The agencies that show up include the DEA for controlled substances, the FDA for imported or compounded products, HHS-OIG and the DOJ when federal programs are billed, and on the state side the Department of Health, the boards of medicine and nursing, and the Attorney General. A single clinic can face several of them at once.
Med spa cases get charged under a wide range of theories, because the conduct touches so many rules at once. Knowing which theory the government is building is the first step in defending it.
Unlicensed or unauthorized practice of medicine. Many states require that medical procedures be performed or properly supervised by a physician, and that prescriptions follow a real patient relationship. When a non-physician owner directs care, or a medical director exists only on paper, prosecutors allege practice of medicine without a license or beyond its scope.
Improper supervision and delegation. Even where nurses or physician assistants can perform procedures, they usually must do so under defined supervision and protocols. Cases are built on the gap between what the law required and what actually happened on the floor.
Controlled substance and prescribing violations. Prescribing without a legitimate medical purpose, or outside a valid practitioner relationship, can bring DEA scrutiny and federal charges under the Controlled Substances Act.
Drug importation, misbranding, and adulteration. Ordering injectables or weight-loss drugs from foreign or unapproved sources can lead to charges involving misbranded or adulterated drugs under federal food and drug law.
Healthcare fraud and billing fraud. If a clinic bills insurance, including disguising cosmetic procedures as medically necessary ones, the government can charge healthcare fraud, often paired with wire fraud for electronic claims.
Anti-Kickback violations. Paying for patient referrals, or structuring arrangements with marketers, telehealth companies, or other providers, can trigger the federal Anti-Kickback Statute when federal program dollars are involved.
Identity theft and access device fraud. When patient or payment information is misused, these charges can be layered on top, raising the exposure significantly.
These theories are often stacked. One case can include a state licensing charge, a federal controlled-substance count, and a fraud count, each with its own consequences.
Behind the labels, most of these cases come down to a few practical questions, and prosecutors have to answer all of them.
Did the people performing or supervising procedures have the legal authority to do so in the way the law required? For prescribing cases, was there a real medical evaluation, or a prescription with no genuine relationship behind it? For fraud cases, was there intent to deceive, billing for something that did not happen or was not what it claimed to be? For drug cases, did you knowingly handle the products in a way the law forbids?
Intent is usually the battleground. There is a real difference between an owner who deliberately ran an illegal operation and one who built a clinic on advice from consultants, lawyers, and a medical director and got some rules wrong. The government has to prove the first. The facts often show the second.
The consequences stretch far beyond a courtroom.
On the criminal side, exposure depends on the charges. Federal drug, fraud, and kickback counts can carry years in prison, fines, restitution, and forfeiture of clinic assets and proceeds. State unlicensed-practice and prescribing charges carry their own penalties, including jail in serious cases.
For licensed professionals, the licensing consequences can be the worst part. A nurse, nurse practitioner, physician assistant, or physician can face suspension or permanent loss of a license, and a board action can move on a faster track than the criminal case.
For the business, the clinic itself is at risk through closure, asset freezes, forfeiture, and the loss of relationships with pharmacies, distributors, and payment processors. Civil liability often follows.
For non-citizen owners or staff, certain charges carry immigration consequences, including removal.
The combination of criminal exposure, license loss, and the destruction of a business all at once is what makes these cases so dangerous, and why they need someone who understands all three fronts.
These cases are not defended with a generic playbook. They are defended by understanding exactly how the clinic operated and where the government's theory breaks down.
Attacking intent and knowledge. Fraud, kickback, and many prescribing charges require proof that you acted knowingly and meant to break the law. A clinic built on the advice of consultants, a medical director, a telehealth platform, and counsel often reflects an honest attempt to comply, not a scheme. Building that record can defeat the central element.
Reliance on professionals. Many med spa owners are not doctors. They relied on a medical director, a compliance consultant, a telehealth company, or a lawyer to tell them how to set things up. Good-faith reliance on professional advice can be a strong defense to charges that turn on intent.
Challenging the supervision and licensing theory. These cases often hinge on fact-specific questions about who did what and under which protocols, and the government's version is frequently built on one former employee's account. The actual training, protocols, and oversight can take that apart.
Scrutinizing the prescribing evidence. Whether a prescription served a legitimate medical purpose is a clinical question, not a slogan. Records and standard practice in the field can show the prescribing was appropriate.
Examining the source and handling of products. In importation and misbranding cases, the chain of custody, the real contents of the products, and what you knew about the source all matter. The government's assumptions do not always hold up.
Witness credibility. Disgruntled former employees, competitors, and cooperators drive many of these cases. Their motives and inconsistencies are fair game.
Search and procedural challenges. Records seized through a flawed warrant, or evidence gathered in violation of your rights, may be subject to suppression.
Separating the state and federal tracks. Board, state criminal, and federal proceedings can run at the same time. A statement in a board matter can be used in a criminal case, so the defense has to be coordinated across all of them.
Med spa investigations give you warning signs before they become charges. The clinics that survive them usually acted on those signs early.
A board complaint, a records request from the Department of Health, a DEA inspection, an FDA inquiry about a product, a former employee who suddenly went quiet. Each can be the visible edge of something larger. Treated as a nuisance, they grow. Treated seriously, they can sometimes be contained.
Before charges are filed, there is room to respond to a target letter, answer a subpoena correctly, present your side to a prosecutor, and in some cases show that what they are seeing is a compliance gap, not a crime. There is also room to protect your license, your operations, and your accounts before they are frozen.
The window narrows fast once the criminal and licensing tracks pick up speed. Voluntary interviews, informal board meetings, and casual conversations with investigators feel low-stakes but are often where cases are made. None of them should be handled without counsel.
Med spa owners, nurses, and physicians who call AMC Defense Law are usually facing more than one charge. They are facing a threat to their license, their clinic, and their freedom at the same time, and they need someone who can see the whole picture.
Aaron M. Cohen has more than thirty years of experience defending serious state and federal cases, including healthcare fraud, controlled-substance, and white collar matters. That background matters in this industry, where a defense has to account for criminal law, drug law, and professional licensing at once.
The firm's role is to understand how your clinic actually worked, find the weaknesses in the government's theory, keep you from making the situation worse, and fight on every front the case is being pursued on.
If your med spa has received a complaint, a records request, a DEA or FDA inquiry, a subpoena, or a target letter, or if you have learned an employee is talking to investigators, the time to bring in a lawyer is now, while you still have options.
These cases are most dangerous when they are left to grow unattended, and most defensible when someone gets ahead of them.
To discuss your situation confidentially with Aaron M. Cohen, contact AMC Defense Law to arrange a consultation.
Yes. Owners, managers, and staff can all face exposure depending on how the clinic operated, who performed procedures, and how it was supervised and billed. In unlicensed-practice theories, ownership by a non-physician can be the central issue.
It can become one. Board and health-department complaints are often the starting point for a broader investigation, and information from a regulatory inquiry can feed a criminal file. It should be taken seriously from the start.
The weight-loss drug boom has drawn heavy scrutiny over how these drugs are prescribed, sourced, and sold. Problems arise when prescriptions are issued without a real evaluation, when products come from compounded or imported sources, or when the practice runs afoul of controlled-substance or food-and-drug rules.
Not always, but it is a serious signal. DEA involvement points to controlled-substance concerns, and an inspection can come before enforcement. It should prompt a call to counsel, not a wait-and-see approach.
Potentially significant. Importing injectables from foreign or unapproved sources can lead to charges involving misbranded or adulterated drugs and can draw in the FDA. What you knew about the source and the products matters.
In some cases, yes. Forfeiture lets the government pursue money and property it claims is connected to the alleged offense, and accounts can be frozen during an investigation.
It can be a central one. Many states require genuine physician supervision, and a paper medical director who never actually oversaw care is a common basis for unlicensed-practice and improper-supervision charges. How the relationship actually worked matters.
Your license is at risk, and the board process can move independently of any criminal case. Because statements in a licensing matter can affect the criminal case, the two need to be defended together.
Former employees drive many of these cases, and their accounts can be powerful. They can also be biased or mistaken, and their credibility is something a defense can challenge.
The firm defends serious state and federal criminal matters and understands how licensing exposure interacts with them. It handles federal investigations nationwide, and many med spa cases involve federal agencies and conduct crossing state lines.
Florida ranked second in a 14,748-site med spa menu study. If your site lists GLP-1s, IV drips or testosterone, see what each line tells an investigator.
Own a Florida med spa? Utah's draft bill sets a 60-mile rule for Botox and RN-only injections. See how that same checklist feeds felony charges in Florida.
Bought discounted semaglutide in 2023 or 2024? A Tampa counterfeit Ozempic indictment shows what FDA agents trace. Learn your exposure and what to do first.
Does your significant difference note read the same for every patient? FDA's September 2026 warning letter calls that pretextual. Your exposure, and the fix.
Counterfeit Botox drew 46 months and $2 million in federal judgments. What turned it into a prison case, and how Florida injectors and owners avoid that path.
FDA already wrote to you once. That older letter is how a strict liability misdemeanor becomes a three-year felony, and what you ship next is knowing conduct.
A Form 483 lists what FDA investigators observed during an inspection. FDA asks for a response within 15 business days and may not consider a late one when it decides what happens next. A warning letter is FDA's formal notice of significant violations, with a response due in 15 working days, and it is published on FDA's website. Neither is a criminal charge. Both build the record FDA and the Department of Justice rely on if the matter escalates, and what you say in the response becomes part of that record.
Advisory before the enforcement action. Defense after it. AMC Defense Law represents peptide vendors, compounding pharmacies, outsourcing facilities, telehealth platforms, med spas, prescribers, importers, and their owners in FDA, DOJ, state board, and state attorney general matters nationwide.
Federal healthcare fraud cases are built from claims data before anyone is interviewed. By the time HHS-OIG or FBI agents knock, the government usually has months or years of billing analysis, and often a cooperating insider. The defense has to start where the government started: the data, the medical records that support or undercut medical necessity, and the financial relationships behind the referrals.
An Anti-Kickback investigation usually means the government believes money changed hands to influence where patients or healthcare business went. These cases are built quietly, often alongside a sealed whistleblower lawsuit you do not even know exists.